Richard Peter Marshall
CIK: 0002016188
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Serina Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 17, 2026SER
Serina Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
15.3K shares- - May 19, 2026SER
Serina Therapeutics, Inc.
Purchase(P)Direct12.2K shares at avg. $1.65$20K - Nov 7, 2025SER
Serina Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
10K shares-
1-3 of 3 transactions
About Marshall Richard Peter
Marshall Richard Peter (SEC CIK 0002016188) files insider reports with the SEC as Director of Serina Therapeutics, Inc. (SER).
Signal8 holds 3 ownership filings by Marshall Richard Peter, all Form 4s, filed between Nov 10, 2025 and Jun 22, 2026. Those filings report 3 transactions, from Nov 7, 2025 to Jun 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Marshall Richard Peter's filings is in HUNTSVILLE, AL.
Recent filings by Marshall Richard Peter
Other insiders filing for Serina Therapeutics, Inc. (SER)
- Simon Farrell, Director
- Brannan Stephen K., Director
- Venkatesan Jay, Director
- Bailey Gregory, Director
- WILSON KAREN J, Director
- LEDGER STEVEN A, Chief Executive Officer